LFCR
Lifecore Biomedical Inc (LFCR)
Healthcare • NASDAQ • $4.79+0.42%
- Symbol
- LFCR
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Price
- $4.79
- Daily Change
- +0.42%
- Market Cap
- $179.67M
- Trailing P/E
- N/A
- Forward P/E
- -5.84
- 52W High
- $8.98
- 52W Low
- $3.63
- Analyst Target
- $6.67
- Dividend Yield
- N/A
- Beta
- 1.08
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development ser…
Company websiteResearch LFCR on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.